Abstract
Arsenic (AS) is a metalloid element that widely exists and can cause different degrees of liver damage. The molecular mechanism of arsenic-induced liver injury has yet to be fully elucidated. Clinically, glutathione (GSH) is often used as an antidote for heavy metal poisoning and hepatoprotective drugs. However, the hepatoprotective effect of glutathione remains unknown in arsenic-induced liver injury. The regulatory relationship between Foxa2 and XIAP may play an important role in mitochondrial survival and death. Therefore, we took Foxa2-XIAP as the axis to explore the protective mechanism of GSH. In this study, we first established a mouse model of chronic arsenic exposure and examined liver function as reflected by quantitative parameters such as aspartate aminotransferase and alanine aminotransferase. Also, redox parameters in the liver were measured, including malondialdehyde, superoxide dismutase, 8-hydroxy-2′-deoxyguanosin, and glutathione peroxidase. RT-qPCR and western-blotting were used to detect the levels of related genes and proteins, such as Foxa2, XIAP, Smac, Bax, Bcl2, Caspase9, and Caspase3. Subsequently, GSH was administered at the same time as high arsenic exposure, and changes in the above parameters were observed. After a comprehensive analysis of the above results, we demonstrate that GSH treatment alleviates arsenic-induced oxidative stress and inhibits the mitochondrial pathway of apoptosis, which can be regulated through the Foxa2 and XIAP axis. The present study would be helpful in elucidating the molecular mechanism of arsenic-induced liver injury and identifying a new potential therapeutic target. And we also provided new theoretical support for glutathione in the treatment of liver damage caused by arsenic.
Similar content being viewed by others
Data Availability
The data contained in the paper is available.
References
Mandal BK, Suzuki KT (2002) Arsenic round the world: a review. Talanta 58(1):201–235
Podgorski J, Berg M (2020) Global threat of arsenic in groundwater. Science 368(6493):845–850. https://doi.org/10.1126/science.aba1510
George CM, Sima L, Arias MH et al (2014) Arsenic exposure in drinking water: an unrecognized health threat in Peru. Bull World Health Organ 92(8):565–572. https://doi.org/10.2471/BLT.13.128496
Zhang W, Gao Y, Yu G et al (2021) Progress in the prevention and control of water-borne arsenicosis in China. Int J Environ Health Res 31(5):548–557. https://doi.org/10.1080/09603123.2019.1674255
Bhowmick S, Pramanik S, Singh P, Mondal P, Chatterjee D, Nriagu J (2018) Arsenic in groundwater of West Bengal, India: a review of human health risks and assessment of possible intervention options. Sci Total Environ 612:148–169. https://doi.org/10.1016/j.scitotenv.2017.08.216
Rahaman MS, Rahman MM, Mise N et al (2021) Environmental arsenic exposure and its contribution to human diseases, toxicity mechanism and management. Environ Pollut 289:117940. https://doi.org/10.1016/j.envpol.2021.117940
Torres-Avila M, Leal-Galicia P, Sánchez-Peña LC, Del Razo LM, Gonsebatt ME (2010) Arsenite induces aquaglyceroporin 9 expression in murine livers. Environ Res 110(5):443–447. https://doi.org/10.1016/j.envres.2009.08.009
Mazumder DN (2005) Effect of chronic intake of arsenic-contaminated water on liver. Toxicol Appl Pharmacol 206(2):169–175. https://doi.org/10.1016/j.taap.2004.08.025
Frediani JK, Naioti EA, Vos MB, Figueroa J, Marsit CJ, Welsh JA (2018) Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005–2014. Environ Health 17(1):6. Published 2018 Jan 15. https://doi.org/10.1186/s12940-017-0350-1
Jomova K, Jenisova Z, Feszterova M et al (2011) Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol 31(2):95–107. https://doi.org/10.1002/jat.1649
Sinha K, Das J, Pal PB, Sil PC (2013) Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 87(7):1157–1180. https://doi.org/10.1007/s00204-013-1034-4
Moussata D, Amara S, Siddeek B et al (2012) XIAP as a radioresistance factor and prognostic marker for radiotherapy in human rectal adenocarcinoma. Am J Pathol 181(4):1271–1278. https://doi.org/10.1016/j.ajpath.2012.06.029
Wu Y, Lu S, Huang X et al (2022) Targeting cIAPs attenuates CCl4-induced liver fibrosis by increasing MMP9 expression derived from neutrophils. Life Sci 289:120235. https://doi.org/10.1016/j.lfs.2021.120235
Sharma S, Kaufmann T, Biswas S (2017) Impact of inhibitor of apoptosis proteins on immune modulation and inflammation. Immunol Cell Biol 95(3):236–243. https://doi.org/10.1038/icb.2016.101
Vaux DL, Korsmeyer SJ (1999) Cell death in development. Cell 96(2):245–254. https://doi.org/10.1016/s0092-8674(00)80564-4
Wu G, Chai J, Suber TL et al (2000) Structural basis of IAP recognition by Smac/DIABLO. Nature 408(6815):1008–1012. https://doi.org/10.1038/35050012
Wolfrum C, Asilmaz E, Luca E, Friedman JM, Stoffel M (2004) Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes. Nature 432(7020):1027–1032. https://doi.org/10.1038/nature03047
Wang K, Brems JJ, Gamelli RL, Holterman AX (2013) Foxa2 may modulate hepatic apoptosis through the cIAP1 pathway. Cell Signal 25(4):867–874. https://doi.org/10.1016/j.cellsig.2012.12.012
Chen Y, Dong H, Thompson DC, Shertzer HG, Nebert DW, Vasiliou V (2013) Glutathione defense mechanism in liver injury: insights from animal models. Food Chem Toxicol 60:38–44. https://doi.org/10.1016/j.fct.2013.07.008
Short JD, Downs K, Tavakoli S, Asmis R (2016) Protein thiol redox signaling in monocytes and macrophages. Antioxid Redox Signal 25(15):816–835. https://doi.org/10.1089/ars.2016.6697
IARC (International Agency for Research on Cancer) (2004) Monographs on evaluation of carcinogenic risk to humans. Some Drinking Water Disinfectants Contam Incl Arsenic 84:269–477
Islam K, Haque A, Karim R et al (2011) Dose-response relationship between arsenic exposure and the serum enzymes for liver function tests in the individuals exposed to arsenic: a cross sectional study in Bangladesh. Environ Health 10:64. https://doi.org/10.1186/1476-069X-10-64
Dong Z (2002) The molecular mechanisms of arsenic-induced cell transformation and apoptosis. Environ Health Perspect 110(Suppl 5):757–759. https://doi.org/10.1289/ehp.02110s5757
Wang C, Zhang W, He Y et al (2021) Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects. Nat Nanotechnol 16(12):1413–1423. https://doi.org/10.1038/s41565-021-00980-7
Zhao Y, Yuan B, Onda K, et al (2018) Anticancer efficacies of arsenic disulfide through apoptosis induction, cell cycle arrest, and pro-survival signal inhibition in human breast cancer cells. Am J Cancer Res.8(3):366–386. Published 2018 Mar 1
Lengfelder E, Hofmann WK, Nowak D (2012) Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia. Leukemia 26(3):433–442. https://doi.org/10.1038/leu.2011.245
Lo-Coco F, Avvisati G, Vignetti M et al (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 369(2):111–121. https://doi.org/10.1056/NEJMoa1300874
Huang H, Wu Q, Guo X et al (2021) O-GlcNAcylation promotes the migratory ability of hepatocellular carcinoma cells via regulating FOXA2 stability and transcriptional activity. J Cell Physiol 236(11):7491–7503. https://doi.org/10.1002/jcp.30385
Xu J, Hua X, Yang R et al (2019) XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion. Oncogenesis 8(12):71. https://doi.org/10.1038/s41389-019-0181-8
Foster FM, Owens TW, Tanianis-Hughes J et al (2009) Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer. Breast Cancer Res 11(3):R41. https://doi.org/10.1186/bcr2328
Dubrez-Daloz L, Dupoux A, Cartier J (2008) IAPs: more than just inhibitors of apoptosis proteins. Cell Cycle 7(8):1036–1046. https://doi.org/10.4161/cc.7.8.5783
Abbas R, Larisch S (2020) Targeting XIAP for promoting cancer cell death-the story of ARTS and SMAC. Cells. 9(3):663. https://doi.org/10.3390/cells9030663
Dominko K, Đikić D (2018) Glutathionylation: a regulatory role of glutathione in physiological processes. Arh Hig Rada Toksikol 69(1):1–24. https://doi.org/10.2478/aiht-2018-69-2966
Funding
This study was supported by grants from the National Natural Science Foundation of China (grant no. 81773367).
Author information
Authors and Affiliations
Contributions
Hua Zhang, Baiming Jin, and Kewei Wang developed the hypothesis and study design. All authors contributed to the study concept, analysis, and interpretation of the data. All authors approved the final manuscript for submission.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate Animal Ethics
All procedures were approved by the Animal Use Ethics Committee of the Chinese Center for Disease Control and Prevention, Harbin Medical University (approval ID: hrbmuecdc20170306).
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zhang, H., Jin, B., Liu, L. et al. Glutathione Might Attenuate Arsenic-Induced Liver Injury by Modulating the Foxa2-XIAP Axis to Reduce Oxidative Stress and Mitochondrial Apoptosis. Biol Trace Elem Res 201, 5201–5212 (2023). https://doi.org/10.1007/s12011-023-03577-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-023-03577-4